Study to Assess the Safety, Tolerability, and Pharmacokinetics of HFB30132A Against COVID-19 in Healthy Adults
Clinical trial NCT04590430 · COMPLETED
Trial details
- NCT number
- NCT04590430
- Sponsor
- HiFiBiO Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-20
- Primary completion
- 2021-07-26
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.